Replies to post #235238 on Biotech Values

[DewDiligence]

GSK stops trial of maternal RSV vaccine:

https://www.sec.gov/Archives/edgar/data/0001131399/000165495422002150/glaxf_6k.htm

GlaxoSmithKline plc today announced that, further to the voluntary pause shared on February 18, the Company has decided to stop enrolment and vaccination in trials evaluating its potential respiratory syncytial virus (RSV) maternal vaccine candidate in pregnant women (NCT04605159, NCT04980391, NCT05229068).

Further analysis to better understand safety data from these trials is ongoing, and the relevant regulatory authorities have been informed.